
### [NCIT:C8523](http://purl.obolibrary.org/obo/NCIT_C8523)
**Label:** Stage IV Non-Hodgkin Lymphoma

**Subclasses:** [NCIT:C7802](http://purl.obolibrary.org/obo/NCIT_C7802) (Stage IV Mycosis Fungoides), [NCIT:C8879](http://purl.obolibrary.org/obo/NCIT_C8879) (Stage IV Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8857](http://purl.obolibrary.org/obo/NCIT_C8857) (Stage IV Diffuse Large B-Cell Lymphoma), [NCIT:C5006](http://purl.obolibrary.org/obo/NCIT_C5006) (Stage IV Follicular Lymphoma), [NCIT:C8656](http://purl.obolibrary.org/obo/NCIT_C8656) (Stage IV Lymphoplasmacytic Lymphoma), [NCIT:C8931](http://purl.obolibrary.org/obo/NCIT_C8931) (Stage IV Centroblastic Lymphoma), [NCIT:C8679](http://purl.obolibrary.org/obo/NCIT_C8679) (Stage IV Angioimmunoblastic T-cell Lymphoma), [NCIT:C5088](http://purl.obolibrary.org/obo/NCIT_C5088) (Stage IV Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C94794](http://purl.obolibrary.org/obo/NCIT_C94794) (Stage IV Childhood Non-Hodgkin Lymphoma), [NCIT:C8873](http://purl.obolibrary.org/obo/NCIT_C8873) (Stage IV B Lymphoblastic Lymphoma), [NCIT:C8675](http://purl.obolibrary.org/obo/NCIT_C8675) (Stage IV Nasal Type NK/T-Cell Lymphoma), [NCIT:C115032](http://purl.obolibrary.org/obo/NCIT_C115032) (Stage IV Childhood Anaplastic Large Cell Lymphoma), [NCIT:C5084](http://purl.obolibrary.org/obo/NCIT_C5084) (Stage IV Burkitt Lymphoma), [NCIT:C8693](http://purl.obolibrary.org/obo/NCIT_C8693) (Stage IV Mature T- and NK-Cell Lymphoma), [NCIT:C9188](http://purl.obolibrary.org/obo/NCIT_C9188) (Stage IV Childhood Burkitt Lymphoma), [NCIT:C8141](http://purl.obolibrary.org/obo/NCIT_C8141) (Stage IV Small Lymphocytic Lymphoma), [NCIT:C88160](http://purl.obolibrary.org/obo/NCIT_C88160) (Stage IV Mycosis Fungoides and Sezary Syndrome), [NCIT:C8845](http://purl.obolibrary.org/obo/NCIT_C8845) (Stage IV B-Cell Non-Hodgkin Lymphoma), [NCIT:C8867](http://purl.obolibrary.org/obo/NCIT_C8867) (Stage IV Nodal Marginal Zone Lymphoma), [NCIT:C8668](http://purl.obolibrary.org/obo/NCIT_C8668) (Stage IV T-Cell Non-Hodgkin Lymphoma), [NCIT:C8105](http://purl.obolibrary.org/obo/NCIT_C8105) (Stage IV Adult Non-Hodgkin Lymphoma), [NCIT:C8685](http://purl.obolibrary.org/obo/NCIT_C8685) (Stage IV Enteropathy-Associated T-Cell Lymphoma), [NCIT:C9059](http://purl.obolibrary.org/obo/NCIT_C9059) (Stage IV Childhood Lymphoblastic Lymphoma), [NCIT:C8487](http://purl.obolibrary.org/obo/NCIT_C8487) (Stage IV Aggressive Adult Non-Hodgkin Lymphoma), [NCIT:C8485](http://purl.obolibrary.org/obo/NCIT_C8485) (Stage IV Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C8486](http://purl.obolibrary.org/obo/NCIT_C8486) (Stage IV Mantle Cell Lymphoma), [NCIT:C8145](http://purl.obolibrary.org/obo/NCIT_C8145) (Stage IV Grade 3 Follicular Lymphoma), [NCIT:C8662](http://purl.obolibrary.org/obo/NCIT_C8662) (Stage IV Anaplastic Large Cell Lymphoma), [NCIT:C8142](http://purl.obolibrary.org/obo/NCIT_C8142) (Stage IV Grade 1 Follicular Lymphoma), [NCIT:C8143](http://purl.obolibrary.org/obo/NCIT_C8143) (Stage IV Grade 2 Follicular Lymphoma), [NCIT:C8151](http://purl.obolibrary.org/obo/NCIT_C8151) (Stage IV Adult Lymphoblastic Lymphoma), [NCIT:C8152](http://purl.obolibrary.org/obo/NCIT_C8152) (Stage IV Adult Burkitt Lymphoma), [NCIT:C8150](http://purl.obolibrary.org/obo/NCIT_C8150) (Stage IV Adult Immunoblastic Lymphoma), [NCIT:C68683](http://purl.obolibrary.org/obo/NCIT_C68683) (Stage IV Marginal Zone Lymphoma), 

**Class expressions from DL-Learner:**

- [NCIT:C27971](http://purl.obolibrary.org/obo/NCIT_C27971) (Stage IV) 54.55%
- Thing 52.66%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39880](http://purl.obolibrary.org/obo/NCIT_C39880) (Acinar Prostate Adenocarcinoma, Atrophic Variant))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39875](http://purl.obolibrary.org/obo/NCIT_C39875) (Loss of Chromosome 9q))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39874](http://purl.obolibrary.org/obo/NCIT_C39874) (Urethral Verrucous Carcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39873](http://purl.obolibrary.org/obo/NCIT_C39873) (Urethral Glandular Metaplasia))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39872](http://purl.obolibrary.org/obo/NCIT_C39872) (Urethral Villous Adenoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39866](http://purl.obolibrary.org/obo/NCIT_C39866) (Female Urethral Malignant Neoplasm))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39864](http://purl.obolibrary.org/obo/NCIT_C39864) (Carcinoma of Cowper Glands))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39862](http://purl.obolibrary.org/obo/NCIT_C39862) (Human Papillomavirus-Related Urethral Squamous Cell Carcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39859](http://purl.obolibrary.org/obo/NCIT_C39859) (Bladder Inverted Papilloma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39856](http://purl.obolibrary.org/obo/NCIT_C39856) (Urothelial Dysplasia))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39845](http://purl.obolibrary.org/obo/NCIT_C39845) (Bladder Urachal Squamous Cell Carcinoma))) 39.90%


